China's latest move to shore up its economy fell flat with investors. U.S.-listed shares of Chinese companies like Alibaba fell after Beijing extended an $837 billion lifeline to local governments, ...
And, with a lead candidate that keeps reporting good data and advancing through clinical trials ... when a biotech has a candidate that looks like it's a shoo-in for getting approved and subsequently ...